CJC-1295 no DAC+ IPAMORELIN 10mg

CJC-1295 (No DAC) + Ipamorelin is a dual-peptide research formulation commonly utilized in laboratory and preclinical studies examining growth hormone–related signaling pathways and peptide–receptor interactions. This combination pairs a growth hormone–releasing hormone (GHRH) analog with a selective growth hormone secretagogue receptor (GHS-R) agonist, allowing researchers to study complementary mechanisms within controlled experimental environments.

In research settings, CJC-1295 (No DAC) has been examined for its role in stimulating endogenous signaling via GHRH pathways, while Ipamorelin is studied for its receptor selectivity and minimal interaction with non-target hormonal systems. Together, this blend is frequently incorporated into experimental models focused on pulsatile signaling dynamics, endocrine communication, and peptide synergy.

Each vial is manufactured under strict quality standards and independently verified for purity and consistency, supporting reproducible results in advanced research protocols.

Key Research Characteristics

• Dual-peptide research formulation

• Combines GHRH analog and GHS-R agonist pathways

• Studied in endocrine and signaling pathway research models

• High-purity peptides for laboratory consistency

Product Specifications

• Peptides: CJC-1295 (No DAC) + Ipamorelin

• Form: Lyophilized powder

• Purity: ≥99% (HPLC verified)

• Storage: Store in a cool, dry environment; refrigerate after reconstitution per research protocol

Important Notice

This product is for research purposes only.
Not for human or animal consumption.
Not intended to diagnose, treat, cure, or prevent any disease.